Home : FDA Drug Database : Acthar : News Articles

Acthar - News Articles

Thea Singer: Understanding Oprah's Mac-and-Cheese Binge From an Evolutionary Perspective: Palatable foods, stress, and energy stores sculpt corticotropin-releasing factor, adrenocorticotropin, and corticosterone concentrations after restraint. Endocrinology. 2009 May;150(5):2325-33. Epub 2008 Dec 23. Gesta S, Tseng YH, Kahn CR. Developmental origin of fat: tracking obesity ...
Questcor Pharma ç¬¬å››å£Actharå¤„æ–¹è¯å¢žåŠ _è´¢ç»_å‡¤å‡°ç½‘: (QCOR) 16.28 : QuEStcor Pharma??,???????????Acthar????353,??????????,??????66%,?2010??????9%? ...
Untitled Page: Mr. Reichenberger stated "My experience in building commercial infrastructures around orphan therapeutics, especially Acthar(R) Gel, is particularly ...
Raptor Pharmaceutical Hires Patrick Reichenberger to Lead Commercial Development of DR Cysteamine for Nephropathic Cystinosis: Mr. Reichenberger stated “My experience in building commercial infrastructures around orphan therapeutics, especially Acthar(R) Gel, is particularly applicable to Raptor’s nephropathic cystinosis program. I am encouraged by the enthusiastic patient and foundation support for Raptor’s DR ...
MSPD, LOCM, ETFC, QCOR, HAS – Stocks to watch at Opening Bell | Savvy Stock Picks: Questcor's primary drug is HP Acthar Gel (repository corticotropin injection), an injectable drug that is approved by the United States Food and Drug Administration (FDA) for the treatment of a variety of diseases and disorders. Acthar is also used in treating patients ...
Amass Your Fortune With These Stocks (CSX, CVVT, DGW, ICO, PFE, QCOR, WTS): Questcor's top drug, Acthar, which is used to treat multiple sclerosis and has been approved by the FDA for treatment of infantile spasms, is expected to report prescriptions written for it will have grown by 66% when it announces earnings next month. That represents a ...
Pharmazeutische Zeitung online: Stressresistenz: Der kleine Unterschied: Eine wichtige Rolle spielt dabei der Corticotropin Releasing Factor (CRF), der die Ausschüttung von Stresshormonen induziert. Die Forscher setzten Ratten Stresssituationen aus und untersuchten dann die Bindung von CRF an seinen Rezeptor. Diese fiel bei weiblichen Tieren st?rker aus ...

Stressforschung: Warum sind Frauen stressanfälliger als Männer - DCRS ONLINE: ShortNews.de
der Ratten vor und nach dem Stress-Experiment und damit die Tatsache, wie die Corticotropin Releasing Factor-Moleküle an dessen Rezeptoren andockten. Bei den m?nnlichen Ratten setzte nach kurzer Zeit ein Internalisierungsprozess ein. Bei dieser Anpassungsreaktion reduzierten ...
BioWorld Today: Gorman said the company plans to reveal new data from its corticotropin-releasing factor antagonist later this year. Neurocrine also expects to have Phase II data from its Urocortin 2 congestive heart failure program early next year, he said, adding that the company's ...
Corticotropin-releasing Hormone-receptor 2 Needed For Acute Stress-induced Bladder Vascular Permeability And Release Of VEGF: UroToday.com - Stress often induces or aggravates the symptoms of BPS/IC. An increase in the number of activated mast cells has often been reported in the bladder of these patients. The expression of vascular endothelial growth factor (VEGF) has been reported to be increased ...
Stressed? We Know Why...: Daily Beauty Reporter: Beauty Reporter Blog: allure.com: Philadelphia Magazine (blog)
of Philadelphia found that female rat brains are more sensitive to a hormone produced at times of anxiety called "corticotropin-releasing factor" (CRT). ...
Two UK developers report progress with Parkinson's drugs; Discovery Labs gets $35M financing line; - FierceBiotech: Story > Questcor Pharmaceuticals says that the PDUFA date for its supplemental new drug application to approve Acthar for the treatment of infantile spasms (IS) has been extended to September 11, 2010. Questcor release And Finally... How is ...
Oppenheimer Upbeat About Questcor Pharmaceuticals (QCOR) | Benzinga.com: The analysts said that although they expect a positive decision from the FDA for the use of Questcor Pharmaceuticals' Acthar to treat infantile spasms, a delayed decision would have no effect on sales because Acthar has been the standard treatment for infantile spasms ...

Looking for an Acthar lawyer in District of Columbia? Get in touch with one of our Acthar lawyers in District of Columbia now.

Need An Acthar Attorney?

First Name Last Name Email Address State

Legal Issue

FDA Drug Database: Acthar Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

Acthar Information

Click to View Our Legal Resources

Looking for an Acthar lawyer in District of Columbia? Get in touch with one of our Acthar lawyers in District of Columbia now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120521-154419

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

FDA Drug Database: Acthar Click to select a Legal Issue

Close (x)

Find Legal Help for Your Acthar Case - Submit Your Information Below

Do you need legal assistance with your Acthar case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * FDA Drug Database: Acthar Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.